Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An update from DENTSPLY SIRONA ( (XRAY) ) is now available.
On May 21, 2025, DENTSPLY SIRONA held its annual meeting of stockholders where several key decisions were made. These included the election of eleven directors, the ratification of Deloitte and Touche LLP as the company’s independent accountants for 2025, approval of executive compensation for 2024, and an amendment to increase shares under the 2024 Omnibus Incentive Plan. These decisions reflect the company’s ongoing governance and strategic planning efforts.
The most recent analyst rating on (XRAY) stock is a Hold with a $30.00 price target. To see the full list of analyst forecasts on DENTSPLY SIRONA stock, see the XRAY Stock Forecast page.
Spark’s Take on XRAY Stock
According to Spark, TipRanks’ AI Analyst, XRAY is a Neutral.
DENTSPLY SIRONA’s stock is challenged by declining revenue and profitability, high leverage, and operational difficulties, as highlighted in the financial performance. Despite some technical momentum and a high dividend yield, the valuation remains unattractive due to negative earnings. The earnings call underscores operational efficiency but acknowledges significant challenges ahead, contributing to a cautious outlook.
To see Spark’s full report on XRAY stock, click here.
More about DENTSPLY SIRONA
DENTSPLY SIRONA Inc. operates in the dental industry, providing dental products and technologies, including dental equipment and consumables. The company focuses on innovation and quality in the dental market.
Average Trading Volume: 3,377,512
Technical Sentiment Signal: Sell
Current Market Cap: $3.33B
Find detailed analytics on XRAY stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue